StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Lexicon Pharmaceuticals (LXRX) PT Lowered to $25 at Stifel; 'Despite Slow Xermelo Progress, We Still Can’t Reconcile Valuation Here'
February 22, 2018 5:20 PM
Stifel lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Needham & Company Downgrades Lexicon Pharmaceuticals (LXRX) to Hold
February 23, 2018 7:14 AM
Lexicon Pharma (LXRX) Tops Q4 EPS by 14c, Beats on Revenues
February 22, 2018 7:19 AM
Form 8-K LEXICON PHARMACEUTICALS, For: Feb 22
February 22, 2018 7:08 AM
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
February 22, 2018 7:01 AM
